Search results
Combo COVID/flu vaccine elicits higher immune response in trial
United Press International via Yahoo News· 3 days agoAn experimental vaccine that could offer one-stop prevention for both COVID-19 and influenza is...
Moderna says new-generation COVID vaccine more effective than Spikevax
Market Watch· 5 hours agosaid Thursday a Phase 3 trial of its next-generation COVID-19 vaccine met its main goal and showed...
Moderna's combination Covid, flu vaccine is more effective than existing shots in late-stage trial
NBC Los Angeles· 3 days agoModerna said its combination vaccine targeting Covid and the flu was more effective than existing...
Moderna (MRNA) COVID-Flu Combo Jab Meets Late-Stage Study Goal
Zacks via Yahoo Finance· 2 days agoData from a late-stage study shows that Moderna's (MRNA) experimental COVID-19-influenza combination...
3 Reasons to Buy Moderna Stock
Motley Fool via Yahoo Finance· 5 days agoIts success in the COVID-19 vaccine market catapulted it to new heights. However, once the pandemic began subsiding, with a substantial ...
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 23 hours agoModerna stock is making a turnaround after the Food and Drug Administration approved its second-ever...
Moderna president: Company outlook 'stabilizing' thanks to new flu-COVID vaccine data
Yahoo Finance· 2 days ago"What we're kind of settling into now is what feels like more of the normal operations. It's...
Should You Pick Moderna Stock At $150 After 25% Gains In A Month?
Forbes· 6 days agoModerna has a couple of factors to back its strong run. Firstly, the U.S. FDA recently approved ...
Moderna Seeks FDA Approval For Updated COVID-19 Shot For Upcoming Season
Benzinga via AOL· 6 days agoThe submission is based on FDA guidance, which advised that COVID-19 vaccines should be updated to a...
Why Moderna Stock Is a No-Brainer Buy Right Now
Motley Fool via Yahoo Finance· 3 days agoModerna also expects to report results from a phase 3 study of its combination flu-COVID vaccine later this year. Meanwhile, Moderna is evaluating its...
